A previous investigation revealed that EVs derived from HCC, carrying Pyruvate kinase M2 isoform (PKM2), foster the progression of HCC by driving M2 polarization of macrophages and reconfiguring the tumor immune microenvironment [55]. Here, PKM is linked to neoplasm.